W.G. Shaheen & Associates Dba Whitney & CO Teva Pharmaceutical Industries LTD Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$915 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 12, 2018	SELL	$11.23 - $19.1 $161,992 - $275,517	-14,425 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	14,425	14,425 $479,000

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$972 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$820 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$781 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$652 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$600 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account